REQUEST A DEMO
Total
USD $0.00
Search more companies

P42Med Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Basic Organic Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Other Publishers | Data Processing, Hosting, and Related Services | Other Information Services | Internet Publishing and Broadcasting and Web Search Portals | Other Activities Related to Credit Intermediation | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: P42Med Sp. z o.o. Profile Updated: July 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

P42Med Sp. z o.o. is based in Poland. The head office is in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on February 09, 2021. A negative growth of 52.94% was recorded in its total assets.

Headquarters
Ul. Chmielna 73
Warsaw; Mazowieckie; Postal Code: 00-801

Contact Details: Purchase the P42Med Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the P42Med Sp. z o.o. report to view the information.
Registered Capital:
Purchase the P42Med Sp. z o.o. report to view the information.
Incorporation Date:
February 09, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after P42Med Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-57.17%
Operating profit (EBIT)
-57.44%
Net Profit (Loss) for the Period
-54.1%
Total assets
-52.94%
Total equity
-158.01%
Return on Equity (ROE)
-41.3%
Quick Ratio
-0.39%
Cash Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?